Cargando…
Therapeutic Oligonucleotides for Patients with Inflammatory Bowel Diseases
INTRODUCTION: The better understanding of the molecular mechanisms, which drive the pathological process in the gut of patients with Crohn’s disease (CD) and patients with ulcerative colitis (UC), the major forms of inflammatory bowel diseases (IBD) in humans, has facilitated the development of nove...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7305016/ https://www.ncbi.nlm.nih.gov/pubmed/32606588 http://dx.doi.org/10.2147/BTT.S257638 |